24 September 2024 - PHARMAC is widening access to a medicine to treat urinary tract infections and funding a combination medicine for people with Parkinson's disease.
From 1 November 2024, fosfomycin (UroFos), will be funded in the community as for urinary tract infections. It is already funded in hospitals.